Kimberly N Taylor
Papers
2
Total Citations
36
H-Index
2
About
Kimberly N. Taylor is a urologic researcher whose work centers on improving patient outcomes through evidence-based surgical practices and quality-of-life assessment. Her primary research areas include prostate cancer survivorship, patient-reported outcomes, and perioperative safety in urologic oncology. Taylor’s most significant contribution is her work validating the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP), a streamlined questionnaire designed to capture real-time, patient-reported quality of life following robot-assisted radical prostatectomy. Her 2016 study, cited 30 times, demonstrated the feasibility of integrating this tool into routine clinical care, enabling clinicians to better address urinary, bowel, sexual, and hormonal side effects. This work has helped bridge the gap between research instruments and practical, point-of-care use. Additionally, Taylor has investigated the safety of continuing antiplatelet therapy—specifically aspirin and clopidogrel—during robotic partial nephrectomy, providing critical guidance for managing cardiovascular risk during kidney cancer surgery. Her research directly informs clinical decision-making, balancing oncologic control with patient safety and quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2Aspirin and clopidogrel during robotic partial nephrectomy, is it safe?6 citations · 2015